Why Novavax Stock Is Soaring Today
Shares of flu vaccine researcher Novavax (NASDAQ: NVAX) shot up 13.7% in early trading Tuesday after a positive analyst note out of Citigroup predicted "strong market opportunities" for the company's new NanoFlu nanoparticle-based flu vaccine. At last report, however, Novavax shares were spotted retracing their gains -- but still up 6.9% as of 11:40 a.m. EDT.
Image source: Getty Images.
Citigroup gave its stamp of approval to Novavax stock, calling NanoFlu "underappreciated by the Street." According to the analyst, Novavax shares that currently trade for just $1.09 apiece could shoot up as high as $1.60 per share within a year.
Source: Fool.com
Novavax Inc. Aktie
6,35 €
-2,17 %
Die Novavax Inc. Aktie steht recht gut da: Mehr Buy- als Sell-Einschätzungen in der Community.
Ein Kursziel von 11 € für Novavax Inc. würde eine Steigerung von mehr als 50% gegenüber dem aktuellen Kurs von 6.35 € bedeuten.
